Bupropion-Induced Diplopia in an Iranian Patient

We present a case report of bupropion-induced diplopia in a 26-year-old woman who suffered from atypical depression. After four weeks of taking bupropion (225 mg per day) she complained of headaches, blurred vision, and diplopia. No neurological and ophthalmologic abnormal signs were found. Her brai...

Descripción completa

Detalles Bibliográficos
Autores principales: Fayyazi Bordbar, Mohammad Reza, Jafarzadeh, Morteza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mazandaran University of Medical Sciences 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939961/
https://www.ncbi.nlm.nih.gov/pubmed/24644459
_version_ 1782305753470599168
author Fayyazi Bordbar, Mohammad Reza
Jafarzadeh, Morteza
author_facet Fayyazi Bordbar, Mohammad Reza
Jafarzadeh, Morteza
author_sort Fayyazi Bordbar, Mohammad Reza
collection PubMed
description We present a case report of bupropion-induced diplopia in a 26-year-old woman who suffered from atypical depression. After four weeks of taking bupropion (225 mg per day) she complained of headaches, blurred vision, and diplopia. No neurological and ophthalmologic abnormal signs were found. Her brain magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) were normal as well. After tapering off and discontinuing bupropion, her diplopia resolved within a week.
format Online
Article
Text
id pubmed-3939961
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Mazandaran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-39399612014-03-18 Bupropion-Induced Diplopia in an Iranian Patient Fayyazi Bordbar, Mohammad Reza Jafarzadeh, Morteza Iran J Psychiatry Behav Sci Case Report We present a case report of bupropion-induced diplopia in a 26-year-old woman who suffered from atypical depression. After four weeks of taking bupropion (225 mg per day) she complained of headaches, blurred vision, and diplopia. No neurological and ophthalmologic abnormal signs were found. Her brain magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) were normal as well. After tapering off and discontinuing bupropion, her diplopia resolved within a week. Mazandaran University of Medical Sciences 2011 /pmc/articles/PMC3939961/ /pubmed/24644459 Text en © 2011, Iranian Journal of Psychiatry and Behavioral Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Fayyazi Bordbar, Mohammad Reza
Jafarzadeh, Morteza
Bupropion-Induced Diplopia in an Iranian Patient
title Bupropion-Induced Diplopia in an Iranian Patient
title_full Bupropion-Induced Diplopia in an Iranian Patient
title_fullStr Bupropion-Induced Diplopia in an Iranian Patient
title_full_unstemmed Bupropion-Induced Diplopia in an Iranian Patient
title_short Bupropion-Induced Diplopia in an Iranian Patient
title_sort bupropion-induced diplopia in an iranian patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939961/
https://www.ncbi.nlm.nih.gov/pubmed/24644459
work_keys_str_mv AT fayyazibordbarmohammadreza bupropioninduceddiplopiainaniranianpatient
AT jafarzadehmorteza bupropioninduceddiplopiainaniranianpatient

Ejemplares similares